Please enable JavaScript
Powered by Benchmark International Archives - Page 144 of 1941 - Matribhumi Samachar English
Wednesday, February 04 2026 | 03:48:39 PM
Home / International (page 144)

International

SuperQ Quantum and Aegis Critical Energy Defence Sign Memorandum of Understanding to Advance Strategic Energy and Digital Integration

Calgary, Alberta–(Newsfile Corp. – January 5, 2026) – SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) (“SuperQ Quantum“, “SuperQ“, or the “Company“), a leader in hybrid quantum-classical orchestration and advanced optimization platforms, is pleased to announce it has signed a formal Memorandum of Understanding (MOU) with Aegis Critical Energy Defence …

Read More »

Minera Alamos Completes Share Consolidation

Toronto, Ontario–(Newsfile Corp. – January 5, 2026) – Minera Alamos Inc. (TSXV: MAI) (OTCQX: MAIFF) (“Minera Alamos” or the “Company“) is pleased to announce that, pursuant to its news release dated December 30, 2025, the Company’s common shares have been consolidated at a ratio of ten pre-consolidation shares to one post-consolidation share (the “Consolidation“). …

Read More »

Simply Solventless Announces Appointment of Seasoned Executive Charles Vennat to Board of Directors

Calgary, Alberta–(Newsfile Corp. – January 5, 2026) – Simply Solventless Concentrates Ltd. (TSXV: HASH) (“SSC“) is pleased to announce the appointment of seasoned executive Charles Vennat to its board of directors. Charles is an accomplished CEO and corporate director with significant experience leading complex manufacturing, consumer packaged goods and regulated …

Read More »

Kardome Launches Cognition AI: On-Device, Context-Aware Voice UI

Tel Aviv, Israel–(Newsfile Corp. – January 5, 2026) – Kardome, a pioneer in voice AI solutions, today introduced Cognition AI, a breakthrough technology designed to make on-device voice interfaces truly intelligent and bring natural voice interaction to cars, homes, and the workplace, where traditional systems often struggle. Cognition AI, combined …

Read More »

Turnium Appoints Industry Veteran as VP of Global Strategy and Partnerships to Accelerate International Growth

Vancouver, British Columbia–(Newsfile Corp. – January 5, 2026) – Turnium Technology Group Inc. (TSXV: TTGI) (FSE: E48) (“Turnium” or the “Company“), a global leader in Technology-as-a-Service (TaaS) and partner enablement services, is pleased to announce the appointment of Aldo G. Gallone as Vice President of Global Strategy and Partnerships. Mr. …

Read More »

Mogotes Launches C$19M Private Placement and Welcomes CD Capital

Toronto, Ontario–(Newsfile Corp. – January 5, 2026) – Mogotes Metals Inc. (TSXV: MOG) (FSE: OY4) (OTCQB: MOGMF) (“Mogotes“, or the “Company“) is pleased to announce a non-brokered private placement through the issuance of 71,698,113 units (each, a “Unit“) at a price of $0.265 per Unit for aggregate gross proceeds of …

Read More »

Buffalo Potash Announces Start of Trading on the TSXV

Buffalo Potash receives final approval for listing from the TSX Venture Exchange. Buffalo Potash to start trading under the symbol “BUFF” on January 6, 2026. Vancouver, British Columbia–(Newsfile Corp. – January 5, 2026) – Buffalo Potash Corporation (formerly, 1377319 B.C. Ltd.) (TSXV: BUFF) (the “Company“) is pleased to announce that it has received …

Read More »

Pacific Empire Provides 2025 Year-End Corporate Update and Outlines 2026 Strategy Focused on Mineral Systems-Scale Exploration at Trident and Pinnacle

Vancouver, British Columbia–(Newsfile Corp. – January 5, 2026) – Pacific Empire Minerals Corp. (TSXV: PEMC) (“Pacific Empire”, “PEMC” or the “Company”), a copper-gold explorer based in British Columbia, is pleased to provide shareholders with a year-end corporate update summarizing key milestones achieved during 2025 and outlining its strategic priorities for …

Read More »

OS Therapies Provides First Half 2026 Corporate Outlook

Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 program in the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma (Metastatic Osteosarcoma Program) under Accelerated Approval Program Biomarker data from Phase 2b Metastatic Osteosarcoma Program human clinical trial expected to …

Read More »